Supernus Pharmaceuticals's (NASDAQ:SUPN) Q1 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) reported revenue ahead of Wall Street's expectations in Q1 CY2025, with sales up 4.3% year on year to $149.8 million. On the other hand, the company's full-year revenue guidance of $615 million at the midpoint came in 1.6% below analysts' estimates. Its GAAP loss of $0.21 per share was significantly below analysts' consensus estimates.
Is now the time to buy Supernus Pharmaceuticals? Find out in our full research report.
Supernus Pharmaceuticals (SUPN) Q1 CY2025 Highlights:
Revenue: $149.8 million vs analyst estimates of $147.9 million (4.3% year-on-year growth, 1.3% beat)
EPS (GAAP): -$0.21 vs analyst estimates of -$0.01 (significant miss)
Adjusted EBITDA: -$10.23 million vs analyst estimates of $49.3 million (-6.8% margin, significant miss)
The company reconfirmed its revenue guidance for the full year of $615 million at the midpoint
Operating Margin: -6.8%, down from -2.2% in the same quarter last year
Market Capitalization: $1.81 billion
'Our first quarter results reflect, once again, double-digit revenue growth from our core products, as well as strong growth in adjusted operating earnings,' said Jack Khattar, President and CEO of Supernus.
Company Overview
With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals (NASDAQ:SUPN) develops and markets treatments for central nervous system disorders including epilepsy, ADHD, Parkinson's disease, and migraine.
Sales Growth
Examining a company's long-term performance can provide clues about its quality. Any business can have short-term success, but a top-tier one grows for years. Luckily, Supernus Pharmaceuticals's sales grew at a decent 10.7% compounded annual growth rate over the last five years. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers.
Supernus Pharmaceuticals Quarterly Revenue
Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Supernus Pharmaceuticals's recent performance shows its demand has slowed as its revenue was flat over the last two years.
Supernus Pharmaceuticals Year-On-Year Revenue Growth
Supernus Pharmaceuticals also breaks out the revenue for its most important segment, . Over the last two years, Supernus Pharmaceuticals's revenue was flat. This segment has outperformed its total sales during the same period, lifting the company's performance.
This quarter, Supernus Pharmaceuticals reported modest year-on-year revenue growth of 4.3% but beat Wall Street's estimates by 1.3%.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Globus Maritime Sets Date for the Release of First Quarter 2025 Results
GLYFADA, Greece, June 11, 2025 (GLOBE NEWSWIRE) -- Globus Maritime Limited ("Globus," the 'Company', ('we,' or 'our'), (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial results for the three‐month period ended March 31, 2025, after the market closes in New York on Monday, June 16, 2025. About Globus Maritime Limited About Globus Maritime Limited, Globus is an integrated dry bulk shipping company that provides marine transportation services worldwide. The Company's operating fleet consists of nine dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina and other dry bulk cargoes internationally, with a total carrying capacity of 680,622 dead weight tons and a weighted average age of 7.5 years as of June 11, 2025. For further information please contact: Globus Maritime Limited +30 210 960 8300 Athanasios Feidakis Capital Link – New York +1 212 661 7566 Nicolas Bornozis globus@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints
- FDA decision anticipated within four weeks - TORONTO, June 13, 2025 /CNW/ - DRI Healthcare Trust (TSX: (TSX: DHT.U) (the "Trust") today announced KalVista Pharmaceuticals ("KalVista") has disclosed that it has received notice from the U.S. Food and Drug Administration ("FDA") that the FDA will not meet the June 17, 2025 PDUFA goal date for the New Drug Application (NDA) for sebetralstat, due to a heavy workload and agency resourcing issues. KalVista commented that the FDA has not requested additional data or studies and has communicated to KalVista that it anticipates delivering a decision within approximately four weeks. KalVista issued its own press release with the announcement earlier today (link). About DRI Healthcare Trust The Trust is managed by DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the Trust has deployed more than $1.0 billion, acquiring more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol " and in U.S. dollars under the symbol "DHT.U". To learn more, visit or follow us on LinkedIn. SOURCE DRI Healthcare Trust View original content to download multimedia:
Yahoo
2 hours ago
- Yahoo
Stock Market Today: Stocks Make a Comeback From Trade Jitters, Boeing Crash
Stock Market Today: Stocks Make a Comeback From Trade Jitters, Boeing Crash originally appeared on TheStreet. Updated 4:30 p.m. ET Stocks ended higher Thursday, as investors reacted to inflation data, while President Donald Trump pushed for an interest rate cut. The Dow Jones Industrial Average gained 101.85 points, or 0.24%, to finish the session at 42,967.62, while the S&P 500 rose 0.38% to close 6,045.26 and the tech-heavy Nasdaq advanced 0.24% to end the day at 19,662.48. Microsoft hit a 52-week high of $480.40, while Oracle surged 13.3% after the software company beat Wall Street's fourth-quarter earnings expectations. Trump called Federal Reserve Chair Jerome Powell a 'numbskull' as he demanded an interest-rate cut, CNBC reported. Trump claimed that lowering rates by 2 percentage points would save the U.S. $600 billion per year, 'but we can't get this guy to do it.' 'We're going to spend $600 billion a year, $600 billion because of one numbskull that sits here [and says] 'I don't see enough reason to cut the rates now,'' Trump said. Trump added that he was OK with the Fed raising rates if inflation was going up. 'But it's down,' he said, 'and I may have to force something.' Updated 10:55 a.m. ET Perhaps the label to describe Thursday's market is this: It's an inertia market. It sagged at the open, (for good reason with the Air India crash), regained its footing and now is drifting into the close with modest gains. The issues that have dominated everyone's thinking at the open are still there: What will happen with tariffs? Short answer: Unclear and volatile. President Trump planned to impose unilateral tariffs on dozens of trading partners in the coming weeks unless they come up with real trade proposals. What is happening with interest rates? Short answer: The 10-year Treasury yield was at 4.36%, down from Wednesday's 4.427%. What will happen with President Trump's tax bill? Short answer: Not clear if any Senate Republicans will break with the president. How is the economy faring? Short answer: OK. Inflation is seemingly benign. Economic softness has not resulted in layoffs. How is the political stress? We'll find with the Army parade and the protests planned for around the country. One sign of rising tensions: Sen. Alex Padilla, D-Calif., was tossed out of Homeland Security Secretary Kristi Noem's Los Angeles news conference today. So, at 3:40 p.m. ET, the Standard & 500 Index was up 17 points to 6,040. The Nasdaq Composite Index was up 31 points to 19,647. The Dow Jones Industrial Average were up 61 points to 42,927. The index had been down as many as 259 points right after the open. Much of the Dow's performance was due to Boeing () , whose shares were off by nearly 5% after an Air India 787 Dreamliner crashed on takeoff from India's Ahmedabad airport. Only one of 242 people aboard survived. If Boeing was simply flat on the day, the Dow would be up nearly 125 points. So, the market is up, not a lot. But at least not down. It's just been wandering along. Updated 10:55 a.m. ET Stocks pushed into positive territory Thursday despite trade worries and the aftermath of a Boeing 787 airliner crash in India. President Trump said late Wednesday he planned to impose unilateral tariffs on dozens of trading partners in the coming weeks. The administration wants more deals now and expects to send letters to more than 150 countries saying, essentially, make trade offers now or see new tariffs imposed. Boeing () shares were off 5.2% after the Air India 787 crash on a flight to London from India's Ahmedabad airport. The plane crashed after takeoff around 12:30 a.m. EDT. Officials said 242 people aboard the plane with no survivors expected. At 10:55 a.m. EDT, the Standard & 500 Index was up 19 points to 6,041. The Nasdaq Composite Index was up nearly 58 points to 19,674. The Dow Jones Industrial Average was up 6 points to 42,873. The index had been down as many as 259 points right after the open. Much of the decline was due to Boeing. Six of 11 S&P 500 sectors were higher, led by information technology stocks. Oracle () was fueling the tech surge. Palantir Technologies () , Apple () and Microchip Technology () were among the decliners. Oracle shares were up a stunning 14% to $201.69 (a new 52-week high) after the company set the software company set 'stunning' growth targets for next year, according to one analyst. The question now is if Oracle can meet them, Barrons noted. After Wednesday's close the company reported a better than expected 11% jump in sales and targeted even higher growth ahead. The company sees a total cloud growth rate of 40% in fiscal 2026, up from 24% this year. Oracle sees cloud infrastructure growth north of 70% next year, up from 50% this year. Initial jobless claims were unchanged at 248,000, unchanged from a week ago. Many economists are watching this report closely to see how tariffs are affecting the economy. The U.S. labor market appears to be losing steam, in part because of economic uncertainty spawned by President Donald's aggressive tariffs proposals, Reuters said. Continuing claims were estimated at 1.96 million in the week through May 31. That was the highest level since November as the effects of the Covid0-19 pandemic were easing. Updated 9:55 a.m. ET Stocks opened lower on Thursday after President Trump said late Wednesday he planned to impose unilateral tariffs on dozens of trading partners in the coming weeks. But the administration wants more deals now and expects to send letters to more than 150 countries saying, essentially, make trade offers or see new tariffs imposed. The market was also weakened by a 4.4% decline to $204.53 in shares of Boeing after an Air India 787 Dreamliner crashed in India. Airline stocks were generally lower. Oracle () was up more than 10% to $195.30 after the database-software and cloud-services company logged higher-than-expected quarterly revenue and earnings. It said it expected "dramatically higher" revenue growth in the financial year that started recently. Shares of Gamestop () were down 17% to $23.73 after the gaming retailer said it wanted to raise $1.75 billion in a note offering to invest in bitcoin. At 9:55 a.m. ET, the Standard & 500 Index was down 3 points to 6,020. The Nasdaq Composite Index was off 15 points to 19,601. The Dow Jones Industrial Average was off 149 points to 42,717. Much of the decline was due to Boeing. Crude oil was lower. The 10-year Treasury yield was at 4.82%, down from Wednesday's 4.427%. Stocks were facing a weak open after President Trump said late Wednesday he planned to impose unilateral tariffs on dozens of trading partners in the coming weeks. Speaking to reporters at the Kennedy Center, he said the U.S. was very happy about its trade truce reset with China. But the administration wants more deals now and expects to send letters to more than 150 countries saying, essentially, make trade offers or see new tariffs imposed. 💸💰Don't miss the move: Subscribe to TheStreet's free daily newsletter 💰💸 Separately, market jitters intensified amid heightened tensions in the Middle East. Ahead of the open, futures in the Standard & Poor's 500 Index fell 34 points. Nasdaq-100 trading showed a decline of 134 points, and the futures on the Dow Jones Industrial Average were off 288 points. The cautious mood is stalling a rebound in US stocks that had brought the S&P 500 within reach of its all-time high, even as questions about the economic impact of Trump's trade agenda persisted. Decent earnings and limited economic fallout have supported the rally so far. The question is how long the optimism can last. Shares of aerospace giant Boeing () were down about 7.7% to $197.57. A 787 Dreamliner heading to London from India's Ahmedabad crashed after takeoff around 12:30 a.m. EDT. Reports say 242 people were on board. Local authorities told AP that no one appeared to have survived the crash. It was the first crash of a 787 in 14 years of service. Ahmedabad is in Gujarat state in west-central India. The market wasn't helped by another decent report on inflation. The Producer Price Index, which measures price changes that that companies receive, was up 0.1% in May, the Bureau of Labor Statistics said. On an annualized basis, the index was up 2.6% from a year earlier. Core PPI, which strips out energy and prices, was up 2.7%. It probably means the Federal Reserve won't raise interest rates at next week's meeting. Some good news on the earnings front: Oracle () shares were up nearly 9% in premarket trading after the software stalwart beat estimates and offered positive guidance. Stock Market Today: Stocks Make a Comeback From Trade Jitters, Boeing Crash first appeared on TheStreet on Jun 12, 2025 This story was originally reported by TheStreet on Jun 12, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
